European Archives - Page 44 of 1108 - European Medical Journal

Digital Health Interventions Reduce Pregnancy Risks, but Caveats Remain

Digital health cuts excessive pregnancy weight gain by 21%, but caution urged for high-risk groups.

Depression and Gut Symptoms Fuel Disease Progression in Spondyloarthritis

A recent study has found that gastrointestinal symptoms and depression are strongly linked to higher disease activity in spondyloarthritis patients.

Physical Activity Boosts Mental Health in Women with Chronic Pelvic Pain

A recent study tracking over 4,000 days of health data has found that physical activity plays a crucial role in improving mental well-being in women with chronic pelvic pain disorders.

Elevated Salivary Microvesicles Linked to Oral Ulcers and Cancer

Elevated salivary microvesicles are linked to non-healing oral ulcers and oral cancer, potentially aiding in early diagnosis.

HIV Cure Trial in African Women Shows Early Promise

A groundbreaking Phase IIa HIV cure study in South Africa has demonstrated the safety and potential efficacy of a novel therapeutic regimen in women with HIV.

How Alcohol Harms the Digestive System

Despite the significant health burden, there are gaps in managing alcohol-related digestive diseases.

Why Sexual Health Deserves More Attention in Medicine

In this episode of the EMJ Podcast, Jonathan Sackier speaks with Rachel Rubin, a urologist and sexual medicine specialist, about the need for patient-centred care, the importance of multidisciplinary approaches, and breaking the stigma around sexual health.

Psoriasis Treatment Study Confirms Biosimilar Effectiveness

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira.

Evaluation of Antimicrobial Resistance Patterns in Afghanistan

Existing studies reveal alarming levels of AMR in Afghanistan, driven by factors such as self-medication, overuse of antibiotics, and inadequate awareness…

Pfizer completes exit from Haleon

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.